在私募股权改变IVF格局中平衡创新与效率:可持续规模的主张
本文为观点文章,探讨IVF中心规模从独立小单位到跨区域大型网络组织的多样性对临床结局、患者体验、专业实践、创新和长期可持续性的潜在影响。作者承认缺乏高质量比较证据链接组织规模与活产结局或患者报告指标,不主张单一最优规模,而提出「可持续或平衡规模」概念,即运营稳健性、领导力、科学与创新与个性化以患者为中心照护共存的组织平衡。
要点
- IVF中心规模多样,可能影响临床结局、患者体验、专业实践、创新和可持续性。
- 近十年生育领域快速整合,引发中心规模、治理结构与照护质量效率关系的辩论。
- 作者提出「可持续或平衡规模」,强调运营稳健、领导力、科学创新与个性化照护共存。
核心结论
- 不主张单一最优IVF中心规模,而提出「可持续或平衡规模」作为组织平衡概念。
研究设计与样本
- 观点文章,批判性审视小型与大型IVF中心的优势与局限。
主要发现
- IVF中心规模从独立小单位到跨区域大型网络组织不等,多样性可能影响临床结局等多方面。
- 生育领域近十年快速整合,治理模型演变特别是管理和财务决策影响可能重塑科学领导与临床实践。
- 作者承认缺乏高质量比较证据链接组织规模与活产结局或患者报告指标。
临床怎么用
- 临床应关注组织规模与治理结构对个性化以患者为中心照护的影响,追求运营稳健、领导力、科学与创新的平衡。
局限性
- 缺乏高质量比较证据链接组织规模与活产结局或患者报告指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The scale of IVF centres currently ranges from small, stand-alone units to large networked organizations operating across multiple regions or countries. This diversity in organizational models may influence clinical outcomes, patient experience, professional practice, innovation and long-term sustainability. In parallel with broader healthcare trends, the fertility sector has undergone rapid consolidation over the last decade, prompting renewed debate regarding the relationship between centre size, governance structures, quality of care and efficiency. This opinion paper critically examines the strengths and limitations of both small and large IVF centres, with particular attention to the concepts of critical mass, technology adoption, human resources, quality management and professional autonomy. Beyond size alone, the discussion also covers how evolving governance models, particularly the growing influence of managerial and financial decision making, may reshape scientific leadership and clinical practice within fertility centres. Importantly, the authors acknowledge the scarcity of high-quality comparative evidence linking organizational scale to live birth outcomes or patient-reported measures. Rather than advocating for a single optimal size, they propose the concept of a 'sustainable or balanced scale', defined as an organizational equilibrium where operational robustness, leadership, science and innovation coexist with uncompromising personalized, patient-centred care.
引用
- Freour T, Campbell A, Coticchio G, et al. Balancing innovation and efficiency in a private-equity-changed world of IVF: the case for sustainable scale. Reprod Biomed Online. 2026. PMID: 42542019. doi:10.1016/j.rbmo.2026.105846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。